31.85
price down icon2.81%   -0.92
after-market Handel nachbörslich: 31.85
loading
Schlusskurs vom Vortag:
$32.77
Offen:
$33.01
24-Stunden-Volumen:
553.34K
Relative Volume:
0.79
Marktkapitalisierung:
$1.61B
Einnahmen:
$226.84M
Nettoeinkommen (Verlust:
$3.55M
KGV:
455.00
EPS:
0.07
Netto-Cashflow:
$-12.02M
1W Leistung:
-1.82%
1M Leistung:
+1.72%
6M Leistung:
-23.99%
1J Leistung:
-20.55%
1-Tages-Spanne:
Value
$31.34
$33.01
1-Wochen-Bereich:
Value
$31.34
$34.55
52-Wochen-Spanne:
Value
$29.24
$63.00

Vericel Corp Stock (VCEL) Company Profile

Name
Firmenname
Vericel Corp
Name
Telefon
(734) 930-5555
Name
Adresse
64 SIDNEY ST., CAMBRIDGE, MA
Name
Mitarbeiter
357
Name
Twitter
@VericelCorp
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
VCEL's Discussions on Twitter

Vergleichen Sie VCEL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
VCEL
Vericel Corp
31.85 1.65B 226.84M 3.55M -12.02M 0.07
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.79 106.37B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.46 59.90B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.63 60.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
796.92 49.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.10 36.88B 4.56B -176.77M 225.30M -1.7177

Vericel Corp Stock (VCEL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-17 Herabstufung BTIG Research Buy → Neutral
2024-08-09 Eingeleitet Canaccord Genuity Buy
2024-06-20 Eingeleitet TD Cowen Buy
2024-01-25 Hochstufung Truist Hold → Buy
2023-08-08 Hochstufung BTIG Research Neutral → Buy
2022-11-10 Herabstufung BTIG Research Buy → Neutral
2022-11-09 Herabstufung Truist Buy → Hold
2022-10-14 Fortgesetzt Stephens Overweight
2021-01-11 Herabstufung Oppenheimer Outperform → Perform
2020-12-18 Eingeleitet Stephens Overweight
2020-09-17 Eingeleitet Truist Buy
2019-10-09 Eingeleitet H.C. Wainwright Buy
2019-02-28 Herabstufung Needham Buy → Hold
2018-08-08 Bestätigt Needham Buy
2018-07-16 Hochstufung Ladenburg Thalmann Neutral → Buy
2018-04-04 Eingeleitet Leerink Partners Outperform
2018-03-06 Herabstufung Ladenburg Thalmann Buy → Neutral
2018-03-06 Bestätigt Needham Buy
2018-03-05 Bestätigt BTIG Research Buy
2017-06-21 Eingeleitet BTIG Research Buy
2017-03-13 Bestätigt Needham Buy
2016-12-22 Eingeleitet Piper Jaffray Overweight
2016-11-09 Bestätigt Needham Buy
2016-04-05 Herabstufung BofA/Merrill Buy → Neutral
2016-03-11 Hochstufung Needham Hold → Buy
Alle ansehen

Vericel Corp Aktie (VCEL) Neueste Nachrichten

pulisher
Oct 12, 2025

Did Vericel's (VCEL) Strong Earnings Upside Just Shift Its Growth and Investment Narrative? - simplywall.st

Oct 12, 2025
pulisher
Oct 11, 2025

Truist Financial Corp Buys 599 Shares of Vericel Corporation $VCEL - Defense World

Oct 11, 2025
pulisher
Oct 09, 2025

Vericel (NASDAQ:VCEL) Receives "Sell (D+)" Rating from Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

What moving averages say about Vericel Corporation2025 Top Decliners & Consistent Return Investment Signals - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Vericel Corp. Experiences Revision in Its Stock Evaluation Amid Unique Financial Metrics - Markets Mojo

Oct 06, 2025
pulisher
Oct 06, 2025

Will Vericel Corporation see short term momentum2025 AllTime Highs & Growth Focused Entry Reports - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

What data driven models say about Vericel Corporation’s futureEarnings Overview Report & Daily Profit Maximizing Trade Tips - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

State of Alaska Department of Revenue Has $1.28 Million Stock Position in Vericel Corporation $VCEL - Defense World

Oct 05, 2025
pulisher
Oct 04, 2025

Vericel Corporation $VCEL Shares Purchased by PFG Investments LLC - MarketBeat

Oct 04, 2025
pulisher
Oct 03, 2025

Assessing Vericel (VCEL) Valuation After Recent Share Price Volatility - simplywall.st

Oct 03, 2025
pulisher
Oct 03, 2025

Why Vericel Corporation (ATQP) stock gets analyst attention2025 Top Decliners & Expert Approved Trade Ideas - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

GAMMA Investing LLC Cuts Holdings in Vericel Corporation $VCEL - Defense World

Oct 03, 2025
pulisher
Oct 03, 2025

Park Avenue Securities LLC Invests $243,000 in Vericel Corporation $VCEL - Defense World

Oct 03, 2025
pulisher
Oct 03, 2025

Real time breakdown of Vericel Corporation stock performanceFed Meeting & High Accuracy Swing Entry Alerts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

How to manage a losing position in Vericel CorporationCPI Data & Community Consensus Stock Picks - newser.com

Oct 02, 2025
pulisher
Oct 01, 2025

What does recent volatility data suggest for Vericel CorporationWeekly Gains Report & Growth Focused Entry Point Reports - newser.com

Oct 01, 2025
pulisher
Sep 30, 2025

Can Vericel Corporation (ATQP) stock survive global slowdownPrice Action & Precise Entry and Exit Recommendations - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Does Vericel Corporation show high probability of reboundJuly 2025 Pullbacks & Daily Volume Surge Trade Alerts - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

What technical models suggest about Vericel Corporation’s comebackPortfolio Growth Summary & Real-Time Stock Price Movement Reports - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Vericel director Robert Zerbe sells $156,250 in stock - MSN

Sep 29, 2025
pulisher
Sep 29, 2025

Vericel Corp. Experiences Valuation Adjustment Amid Unique Market Dynamics and Performance Metrics - Markets Mojo

Sep 29, 2025
pulisher
Sep 29, 2025

Understanding Vericel Corporation’s price movementAnalyst Downgrade & Fast Entry and Exit Trade Plans - newser.com

Sep 29, 2025
pulisher
Sep 27, 2025

Will Vericel Corporation benefit from macro trendsWall Street Watch & Weekly Top Gainers Trade List - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

Vericel Corp. Hits New 52-Week Low at $29.24 Amidst Declining Performance - Markets Mojo

Sep 27, 2025
pulisher
Sep 26, 2025

Vericel Corporation $VCEL Shares Acquired by Congress Asset Management Co. - Defense World

Sep 26, 2025
pulisher
Sep 25, 2025

Vericel (NASDAQ:VCEL) Hits New 12-Month LowTime to Sell? - MarketBeat

Sep 25, 2025
pulisher
Sep 25, 2025

Vericel stock hits 52-week low at 29.77 USD By Investing.com - Investing.com South Africa

Sep 25, 2025
pulisher
Sep 25, 2025

Vericel stock hits 52-week low at 29.77 USD - Investing.com India

Sep 25, 2025
pulisher
Sep 24, 2025

Kopp Family Office LLC Sells 8,554 Shares of Vericel Corporation $VCEL - MarketBeat

Sep 24, 2025
pulisher
Sep 24, 2025

How to build a custom watchlist for Vericel CorporationQuarterly Earnings Summary & Reliable Intraday Trade Alerts - newser.com

Sep 24, 2025
pulisher
Sep 24, 2025

Diversified Trust Co Grows Stock Holdings in Vericel Corporation $VCEL - Defense World

Sep 24, 2025
pulisher
Sep 24, 2025

Voya Investment Management LLC Purchases 10,048 Shares of Vericel Corporation $VCEL - Defense World

Sep 24, 2025
pulisher
Sep 23, 2025

Strs Ohio Takes Position in Vericel Corporation $VCEL - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Vericel Corporation stock trend forecastQuarterly Risk Review & Long-Term Capital Growth Strategies - newser.com

Sep 23, 2025
pulisher
Sep 22, 2025

Vericel Corp. Experiences Revision in Its Stock Evaluation Amidst Unique Market Metrics - Markets Mojo

Sep 22, 2025
pulisher
Sep 21, 2025

Vericel (NASDAQ:VCEL) Downgraded to Neutral Rating by BTIG Research - MarketBeat

Sep 21, 2025

Finanzdaten der Vericel Corp-Aktie (VCEL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Vericel Corp-Aktie (VCEL) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Hopper Jonathan Mark
Chief Medical Officer
Sep 02 '25
Option Exercise
18.00
10,000
180,000
76,363
Hopper Jonathan Mark
Chief Medical Officer
Sep 02 '25
Sale
35.77
10,000
357,700
66,363
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Kapitalisierung:     |  Volumen (24h):